Table 1. Distribution of clinico-pathological factors in 949 patients with endometrial carcinoma according to body mass index (BMI).
| Variable | Total no. of patients | Median BMI | Lean (%) | Normal (%) | Overweight (%) | Obese (%) | P-valuea |
|---|---|---|---|---|---|---|---|
| Age, quartiles b | 949 | 0.002 | |||||
| 1 (age 26–58) | 25.6 | 5 (2) | 109 (45) | 66 (27) | 65 (27) | ||
| 2 (age 58–66) | 27.1 | 8 (3) | 76 (32) | 82 (34) | 73 (31) | ||
| 3 (age 66–74) | 27.3 | 2 (1) | 76 (31) | 91 (37) | 76 (31) | ||
| 4 (age 74–95) | 25.1 | 8 (4) | 97 (44) | 70 (32) | 45 (21) | ||
| Menopause c | 949 | 0.116 | |||||
| Pre/peri | 26.1 | 1 (1) | 54 (44) | 31 (25) | 38 (31) | ||
| Post | 26.4 | 22 (3) | 304 (37) | 278 (34) | 221 (27) | ||
| FIGO stage | 949 | <0.0001 | |||||
| I | 26.6 | 10 (2) | 246 (36) | 224 (33) | 197 (29) | ||
| II | 27.3 | 3 (3) | 30 (29) | 45 (44) | 26 (25) | ||
| III | 24.4 | 7 (6) | 55 (49) | 30 (27) | 21 (19) | ||
| IV | 24.0 | 3 (6) | 27 (49) | 10 (18) | 15 (27) | ||
| Histological subtype | 949 | ||||||
| Endometrioid | 26.6 | 16 (2) | 297 (37) | 269 (33) | 229 (28) | 0.030 | |
| Non-endometrioid | 25.1 | 7 (5) | 61 (44) | 40 (29) | 30 (22) | ||
| Grade d | 905 | 0.174 | |||||
| 1 or 2 | 26.7 | 14 (2) | 242 (36) | 224 (34) | 188 (28) | ||
| 3 | 25.7 | 9 (4) | 99 (42) | 71 (30) | 58 (25) | ||
| PR | 433 | 0.003e | |||||
| Positive | 26.9 | ||||||
| Negative | 25.5 | ||||||
| ER | 437 | 0.08e | |||||
| Positive | 26.7 | ||||||
| Negative | 25.5 |
Abbreviation: FIGO=International Federation of Gynaecology and Obstetrics.
a
χ2-test when no other specified.
b
Truncated to closest integer.
c
Menopausal status was determined based on the information from the patient records.
d
Data missing for 44 patients.
e
Mann–Whitney U-test.